▶ 調査レポート

世界の経皮パッチドラッグデリバリーシステム市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Transdermal Patch Drug Delivery System Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の経皮パッチドラッグデリバリーシステム市場 2021:企業別、地域別、種類・用途別 / Global Transdermal Patch Drug Delivery System Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A11964資料のイメージです。• レポートコード:GIR-107A11964
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、127ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、経皮パッチドラッグデリバリーシステムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経皮パッチドラッグデリバリーシステムの種類別市場規模(シャントウェイ、細胞内脂質構造経路、経細胞経路)、用途別市場規模(病院、クリニック、在宅ケア、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・経皮パッチドラッグデリバリーシステムの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Hisamitsu Pharmaceutical、Novartis、ProSolus、Tapemark、Tesa Labtec、NITTO DENKO CORPORATION、Noven Pharmaceuticals、LTS Lohmann Therapie-Systeme、Medherant、Corium、Antares Pharma、Syntropharma、Teikoku Pharma、Mylan、Actavis、Mundipharma、Henan Lingrui Pharmaceutical、Changzhou Siyao、Rfl Pharmaceutical
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:シャントウェイ、細胞内脂質構造経路、経細胞経路
・用途別分析2016年-2026年:病院、クリニック、在宅ケア、その他
・経皮パッチドラッグデリバリーシステムの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・経皮パッチドラッグデリバリーシステムのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・経皮パッチドラッグデリバリーシステムのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・経皮パッチドラッグデリバリーシステムの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・経皮パッチドラッグデリバリーシステムの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Transdermal Patch Drug Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Transdermal Patch Drug Delivery System size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Transdermal Patch Drug Delivery System market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Transdermal Patch Drug Delivery System market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Shunt Way
Intercellular Lipid Structure Pathway
Trans-cellular Pathway

Market segment by Application, can be divided into
Hospital
Clinic
Home Care
Other

Market segment by players, this report covers
Hisamitsu Pharmaceutical
Novartis
ProSolus
Tapemark
Tesa Labtec
NITTO DENKO CORPORATION
Noven Pharmaceuticals
LTS Lohmann Therapie-Systeme
Medherant
Corium
Antares Pharma
Syntropharma
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Transdermal Patch Drug Delivery System
1.2 Classification of Transdermal Patch Drug Delivery System by Type
1.2.1 Overview: Global Transdermal Patch Drug Delivery System Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Transdermal Patch Drug Delivery System Revenue Market Share by Type in 2020
1.2.3 Shunt Way
1.2.4 Intercellular Lipid Structure Pathway
1.2.5 Trans-cellular Pathway
1.3 Global Transdermal Patch Drug Delivery System Market by Application
1.3.1 Overview: Global Transdermal Patch Drug Delivery System Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Other
1.4 Global Transdermal Patch Drug Delivery System Market Size & Forecast
1.5 Global Transdermal Patch Drug Delivery System Market Size and Forecast by Region
1.5.1 Global Transdermal Patch Drug Delivery System Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Transdermal Patch Drug Delivery System Market Size by Region, (2016-2021)
1.5.3 North America Transdermal Patch Drug Delivery System Market Size and Prospect (2016-2026)
1.5.4 Europe Transdermal Patch Drug Delivery System Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Transdermal Patch Drug Delivery System Market Size and Prospect (2016-2026)
1.5.6 South America Transdermal Patch Drug Delivery System Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Transdermal Patch Drug Delivery System Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Transdermal Patch Drug Delivery System Market Drivers
1.6.2 Transdermal Patch Drug Delivery System Market Restraints
1.6.3 Transdermal Patch Drug Delivery System Trends Analysis
2 Company Profiles
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Product and Solutions
2.1.4 Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Hisamitsu Pharmaceutical Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Transdermal Patch Drug Delivery System Product and Solutions
2.2.4 Novartis Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 ProSolus
2.3.1 ProSolus Details
2.3.2 ProSolus Major Business
2.3.3 ProSolus Transdermal Patch Drug Delivery System Product and Solutions
2.3.4 ProSolus Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ProSolus Recent Developments and Future Plans
2.4 Tapemark
2.4.1 Tapemark Details
2.4.2 Tapemark Major Business
2.4.3 Tapemark Transdermal Patch Drug Delivery System Product and Solutions
2.4.4 Tapemark Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Tapemark Recent Developments and Future Plans
2.5 Tesa Labtec
2.5.1 Tesa Labtec Details
2.5.2 Tesa Labtec Major Business
2.5.3 Tesa Labtec Transdermal Patch Drug Delivery System Product and Solutions
2.5.4 Tesa Labtec Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Tesa Labtec Recent Developments and Future Plans
2.6 NITTO DENKO CORPORATION
2.6.1 NITTO DENKO CORPORATION Details
2.6.2 NITTO DENKO CORPORATION Major Business
2.6.3 NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Product and Solutions
2.6.4 NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 NITTO DENKO CORPORATION Recent Developments and Future Plans
2.7 Noven Pharmaceuticals
2.7.1 Noven Pharmaceuticals Details
2.7.2 Noven Pharmaceuticals Major Business
2.7.3 Noven Pharmaceuticals Transdermal Patch Drug Delivery System Product and Solutions
2.7.4 Noven Pharmaceuticals Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Noven Pharmaceuticals Recent Developments and Future Plans
2.8 LTS Lohmann Therapie-Systeme
2.8.1 LTS Lohmann Therapie-Systeme Details
2.8.2 LTS Lohmann Therapie-Systeme Major Business
2.8.3 LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Product and Solutions
2.8.4 LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 LTS Lohmann Therapie-Systeme Recent Developments and Future Plans
2.9 Medherant
2.9.1 Medherant Details
2.9.2 Medherant Major Business
2.9.3 Medherant Transdermal Patch Drug Delivery System Product and Solutions
2.9.4 Medherant Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Medherant Recent Developments and Future Plans
2.10 Corium
2.10.1 Corium Details
2.10.2 Corium Major Business
2.10.3 Corium Transdermal Patch Drug Delivery System Product and Solutions
2.10.4 Corium Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Corium Recent Developments and Future Plans
2.11 Antares Pharma
2.11.1 Antares Pharma Details
2.11.2 Antares Pharma Major Business
2.11.3 Antares Pharma Transdermal Patch Drug Delivery System Product and Solutions
2.11.4 Antares Pharma Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Antares Pharma Recent Developments and Future Plans
2.12 Syntropharma
2.12.1 Syntropharma Details
2.12.2 Syntropharma Major Business
2.12.3 Syntropharma Transdermal Patch Drug Delivery System Product and Solutions
2.12.4 Syntropharma Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Syntropharma Recent Developments and Future Plans
2.13 Teikoku Pharma
2.13.1 Teikoku Pharma Details
2.13.2 Teikoku Pharma Major Business
2.13.3 Teikoku Pharma Transdermal Patch Drug Delivery System Product and Solutions
2.13.4 Teikoku Pharma Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Teikoku Pharma Recent Developments and Future Plans
2.14 Mylan
2.14.1 Mylan Details
2.14.2 Mylan Major Business
2.14.3 Mylan Transdermal Patch Drug Delivery System Product and Solutions
2.14.4 Mylan Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Mylan Recent Developments and Future Plans
2.15 Actavis
2.15.1 Actavis Details
2.15.2 Actavis Major Business
2.15.3 Actavis Transdermal Patch Drug Delivery System Product and Solutions
2.15.4 Actavis Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Actavis Recent Developments and Future Plans
2.16 Mundipharma
2.16.1 Mundipharma Details
2.16.2 Mundipharma Major Business
2.16.3 Mundipharma Transdermal Patch Drug Delivery System Product and Solutions
2.16.4 Mundipharma Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Mundipharma Recent Developments and Future Plans
2.17 Henan Lingrui Pharmaceutical
2.17.1 Henan Lingrui Pharmaceutical Details
2.17.2 Henan Lingrui Pharmaceutical Major Business
2.17.3 Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Product and Solutions
2.17.4 Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Henan Lingrui Pharmaceutical Recent Developments and Future Plans
2.18 Changzhou Siyao
2.18.1 Changzhou Siyao Details
2.18.2 Changzhou Siyao Major Business
2.18.3 Changzhou Siyao Transdermal Patch Drug Delivery System Product and Solutions
2.18.4 Changzhou Siyao Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Changzhou Siyao Recent Developments and Future Plans
2.19 Rfl Pharmaceutical
2.19.1 Rfl Pharmaceutical Details
2.19.2 Rfl Pharmaceutical Major Business
2.19.3 Rfl Pharmaceutical Transdermal Patch Drug Delivery System Product and Solutions
2.19.4 Rfl Pharmaceutical Transdermal Patch Drug Delivery System Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Rfl Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Transdermal Patch Drug Delivery System Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Transdermal Patch Drug Delivery System Players Market Share
3.2.2 Top 10 Transdermal Patch Drug Delivery System Players Market Share
3.2.3 Market Competition Trend
3.3 Transdermal Patch Drug Delivery System Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Transdermal Patch Drug Delivery System Revenue and Market Share by Type (2016-2021)
4.2 Global Transdermal Patch Drug Delivery System Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Transdermal Patch Drug Delivery System Revenue Market Share by Application (2016-2021)
5.2 Transdermal Patch Drug Delivery System Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Transdermal Patch Drug Delivery System Revenue by Type (2016-2026)
6.2 North America Transdermal Patch Drug Delivery System Revenue by Application (2016-2026)
6.3 North America Transdermal Patch Drug Delivery System Market Size by Country
6.3.1 North America Transdermal Patch Drug Delivery System Revenue by Country (2016-2026)
6.3.2 United States Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
6.3.3 Canada Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
6.3.4 Mexico Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Transdermal Patch Drug Delivery System Revenue by Type (2016-2026)
7.2 Europe Transdermal Patch Drug Delivery System Revenue by Application (2016-2026)
7.3 Europe Transdermal Patch Drug Delivery System Market Size by Country
7.3.1 Europe Transdermal Patch Drug Delivery System Revenue by Country (2016-2026)
7.3.2 Germany Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
7.3.3 France Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
7.3.5 Russia Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
7.3.6 Italy Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Type (2016-2026)
8.2 Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Application (2016-2026)
8.3 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region
8.3.1 Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Region (2016-2026)
8.3.2 China Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
8.3.3 Japan Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
8.3.4 South Korea Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
8.3.5 India Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
8.3.7 Australia Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Transdermal Patch Drug Delivery System Revenue by Type (2016-2026)
9.2 South America Transdermal Patch Drug Delivery System Revenue by Application (2016-2026)
9.3 South America Transdermal Patch Drug Delivery System Market Size by Country
9.3.1 South America Transdermal Patch Drug Delivery System Revenue by Country (2016-2026)
9.3.2 Brazil Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
9.3.3 Argentina Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Type (2016-2026)
10.2 Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Application (2016-2026)
10.3 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country
10.3.1 Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Country (2016-2026)
10.3.2 Turkey Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
10.3.4 UAE Transdermal Patch Drug Delivery System Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Transdermal Patch Drug Delivery System Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Transdermal Patch Drug Delivery System Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Transdermal Patch Drug Delivery System Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Transdermal Patch Drug Delivery System Revenue (USD Million) by Region (2016-2021)
Table 5. Global Transdermal Patch Drug Delivery System Revenue Market Share by Region (2021-2026)
Table 6. Hisamitsu Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 7. Hisamitsu Pharmaceutical Major Business
Table 8. Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Product and Solutions
Table 9. Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Transdermal Patch Drug Delivery System Product and Solutions
Table 13. Novartis Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ProSolus Corporate Information, Head Office, and Major Competitors
Table 15. ProSolus Major Business
Table 16. ProSolus Transdermal Patch Drug Delivery System Product and Solutions
Table 17. ProSolus Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Tapemark Corporate Information, Head Office, and Major Competitors
Table 19. Tapemark Major Business
Table 20. Tapemark Transdermal Patch Drug Delivery System Product and Solutions
Table 21. Tapemark Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Tesa Labtec Corporate Information, Head Office, and Major Competitors
Table 23. Tesa Labtec Major Business
Table 24. Tesa Labtec Transdermal Patch Drug Delivery System Product and Solutions
Table 25. Tesa Labtec Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. NITTO DENKO CORPORATION Corporate Information, Head Office, and Major Competitors
Table 27. NITTO DENKO CORPORATION Major Business
Table 28. NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Product and Solutions
Table 29. NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Noven Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Noven Pharmaceuticals Major Business
Table 32. Noven Pharmaceuticals Transdermal Patch Drug Delivery System Product and Solutions
Table 33. Noven Pharmaceuticals Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. LTS Lohmann Therapie-Systeme Corporate Information, Head Office, and Major Competitors
Table 35. LTS Lohmann Therapie-Systeme Major Business
Table 36. LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Product and Solutions
Table 37. LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Medherant Corporate Information, Head Office, and Major Competitors
Table 39. Medherant Major Business
Table 40. Medherant Transdermal Patch Drug Delivery System Product and Solutions
Table 41. Medherant Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Corium Corporate Information, Head Office, and Major Competitors
Table 43. Corium Major Business
Table 44. Corium Transdermal Patch Drug Delivery System Product and Solutions
Table 45. Corium Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Antares Pharma Corporate Information, Head Office, and Major Competitors
Table 47. Antares Pharma Major Business
Table 48. Antares Pharma Transdermal Patch Drug Delivery System Product and Solutions
Table 49. Antares Pharma Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Syntropharma Corporate Information, Head Office, and Major Competitors
Table 51. Syntropharma Major Business
Table 52. Syntropharma Transdermal Patch Drug Delivery System Product and Solutions
Table 53. Syntropharma Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Teikoku Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Teikoku Pharma Major Business
Table 56. Teikoku Pharma Transdermal Patch Drug Delivery System Product and Solutions
Table 57. Teikoku Pharma Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Mylan Corporate Information, Head Office, and Major Competitors
Table 59. Mylan Major Business
Table 60. Mylan Transdermal Patch Drug Delivery System Product and Solutions
Table 61. Mylan Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Actavis Corporate Information, Head Office, and Major Competitors
Table 63. Actavis Major Business
Table 64. Actavis Transdermal Patch Drug Delivery System Product and Solutions
Table 65. Actavis Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Mundipharma Corporate Information, Head Office, and Major Competitors
Table 67. Mundipharma Major Business
Table 68. Mundipharma Transdermal Patch Drug Delivery System Product and Solutions
Table 69. Mundipharma Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Henan Lingrui Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 71. Henan Lingrui Pharmaceutical Major Business
Table 72. Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Product and Solutions
Table 73. Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Changzhou Siyao Corporate Information, Head Office, and Major Competitors
Table 75. Changzhou Siyao Major Business
Table 76. Changzhou Siyao Transdermal Patch Drug Delivery System Product and Solutions
Table 77. Changzhou Siyao Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Rfl Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 79. Rfl Pharmaceutical Major Business
Table 80. Rfl Pharmaceutical Transdermal Patch Drug Delivery System Product and Solutions
Table 81. Rfl Pharmaceutical Transdermal Patch Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Global Transdermal Patch Drug Delivery System Revenue (USD Million) by Players (2019-2021)
Table 83. Global Transdermal Patch Drug Delivery System Revenue Share by Players (2019-2021)
Table 84. Breakdown of Transdermal Patch Drug Delivery System by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Transdermal Patch Drug Delivery System Players Head Office, Products and Services Provided
Table 86. Transdermal Patch Drug Delivery System Mergers & Acquisitions in the Past Five Years
Table 87. Transdermal Patch Drug Delivery System New Entrants and Expansion Plans
Table 88. Global Transdermal Patch Drug Delivery System Revenue (USD Million) by Type (2016-2021)
Table 89. Global Transdermal Patch Drug Delivery System Revenue Share by Type (2016-2021)
Table 90. Global Transdermal Patch Drug Delivery System Revenue Forecast by Type (2021-2026)
Table 91. Global Transdermal Patch Drug Delivery System Revenue by Application (2016-2021)
Table 92. Global Transdermal Patch Drug Delivery System Revenue Forecast by Application (2021-2026)
Table 93. North America Transdermal Patch Drug Delivery System Revenue by Type (2016-2021) & (USD Million)
Table 94. North America Transdermal Patch Drug Delivery System Revenue by Type (2021-2026) & (USD Million)
Table 95. North America Transdermal Patch Drug Delivery System Revenue by Application (2016-2021) & (USD Million)
Table 96. North America Transdermal Patch Drug Delivery System Revenue by Application (2021-2026) & (USD Million)
Table 97. North America Transdermal Patch Drug Delivery System Revenue by Country (2016-2021) & (USD Million)
Table 98. North America Transdermal Patch Drug Delivery System Revenue by Country (2021-2026) & (USD Million)
Table 99. Europe Transdermal Patch Drug Delivery System Revenue by Type (2016-2021) & (USD Million)
Table 100. Europe Transdermal Patch Drug Delivery System Revenue by Type (2021-2026) & (USD Million)
Table 101. Europe Transdermal Patch Drug Delivery System Revenue by Application (2016-2021) & (USD Million)
Table 102. Europe Transdermal Patch Drug Delivery System Revenue by Application (2021-2026) & (USD Million)
Table 103. Europe Transdermal Patch Drug Delivery System Revenue by Country (2016-2021) & (USD Million)
Table 104. Europe Transdermal Patch Drug Delivery System Revenue by Country (2021-2026) & (USD Million)
Table 105. Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Type (2016-2021) & (USD Million)
Table 106. Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Type (2021-2026) & (USD Million)
Table 107. Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Application (2016-2021) & (USD Million)
Table 108. Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Application (2021-2026) & (USD Million)
Table 109. Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Region (2016-2021) & (USD Million)
Table 110. Asia-Pacific Transdermal Patch Drug Delivery System Revenue by Region (2021-2026) & (USD Million)
Table 111. South America Transdermal Patch Drug Delivery System Revenue by Type (2016-2021) & (USD Million)
Table 112. South America Transdermal Patch Drug Delivery System Revenue by Type (2021-2026) & (USD Million)
Table 113. South America Transdermal Patch Drug Delivery System Revenue by Application (2016-2021) & (USD Million)
Table 114. South America Transdermal Patch Drug Delivery System Revenue by Application (2021-2026) & (USD Million)
Table 115. South America Transdermal Patch Drug Delivery System Revenue by Country (2016-2021) & (USD Million)
Table 116. South America Transdermal Patch Drug Delivery System Revenue by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Type (2016-2021) & (USD Million)
Table 118. Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Type (2021-2026) & (USD Million)
Table 119. Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Application (2016-2021) & (USD Million)
Table 120. Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Application (2021-2026) & (USD Million)
Table 121. Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Country (2016-2021) & (USD Million)
Table 122. Middle East & Africa Transdermal Patch Drug Delivery System Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Transdermal Patch Drug Delivery System Picture
Figure 2. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type in 2020
Figure 3. Shunt Way
Figure 4. Intercellular Lipid Structure Pathway
Figure 5. Trans-cellular Pathway
Figure 6. Transdermal Patch Drug Delivery System Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Home Care Picture
Figure 10. Other Picture
Figure 11. Global Transdermal Patch Drug Delivery System Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Transdermal Patch Drug Delivery System Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Transdermal Patch Drug Delivery System Revenue Market Share by Region (2016-2026)
Figure 14. Global Transdermal Patch Drug Delivery System Revenue Market Share by Region in 2020
Figure 15. North America Transdermal Patch Drug Delivery System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Transdermal Patch Drug Delivery System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Transdermal Patch Drug Delivery System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Transdermal Patch Drug Delivery System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Transdermal Patch Drug Delivery System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Transdermal Patch Drug Delivery System Market Drivers
Figure 21. Transdermal Patch Drug Delivery System Market Restraints
Figure 22. Transdermal Patch Drug Delivery System Market Trends
Figure 23. Hisamitsu Pharmaceutical Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. ProSolus Recent Developments and Future Plans
Figure 26. Tapemark Recent Developments and Future Plans
Figure 27. Tesa Labtec Recent Developments and Future Plans
Figure 28. NITTO DENKO CORPORATION Recent Developments and Future Plans
Figure 29. Noven Pharmaceuticals Recent Developments and Future Plans
Figure 30. LTS Lohmann Therapie-Systeme Recent Developments and Future Plans
Figure 31. Medherant Recent Developments and Future Plans
Figure 32. Corium Recent Developments and Future Plans
Figure 33. Antares Pharma Recent Developments and Future Plans
Figure 34. Syntropharma Recent Developments and Future Plans
Figure 35. Teikoku Pharma Recent Developments and Future Plans
Figure 36. Mylan Recent Developments and Future Plans
Figure 37. Actavis Recent Developments and Future Plans
Figure 38. Mundipharma Recent Developments and Future Plans
Figure 39. Henan Lingrui Pharmaceutical Recent Developments and Future Plans
Figure 40. Changzhou Siyao Recent Developments and Future Plans
Figure 41. Rfl Pharmaceutical Recent Developments and Future Plans
Figure 42. Global Transdermal Patch Drug Delivery System Revenue Share by Players in 2020
Figure 43. Transdermal Patch Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 44. Global Top 3 Players Transdermal Patch Drug Delivery System Revenue Market Share in 2020
Figure 45. Global Top 10 Players Transdermal Patch Drug Delivery System Revenue Market Share in 2020
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 47. Global Transdermal Patch Drug Delivery System Revenue Share by Type in 2020
Figure 48. Global Transdermal Patch Drug Delivery System Market Share Forecast by Type (2021-2026)
Figure 49. Global Transdermal Patch Drug Delivery System Revenue Share by Application in 2020
Figure 50. Global Transdermal Patch Drug Delivery System Market Share Forecast by Application (2021-2026)
Figure 51. North America Transdermal Patch Drug Delivery System Sales Market Share by Type (2016-2026)
Figure 52. North America Transdermal Patch Drug Delivery System Sales Market Share by Application (2016-2026)
Figure 53. North America Transdermal Patch Drug Delivery System Revenue Market Share by Country (2016-2026)
Figure 54. United States Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Canada Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Mexico Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Europe Transdermal Patch Drug Delivery System Sales Market Share by Type (2016-2026)
Figure 58. Europe Transdermal Patch Drug Delivery System Sales Market Share by Application (2016-2026)
Figure 59. Europe Transdermal Patch Drug Delivery System Revenue Market Share by Country (2016-2026)
Figure 60. Germany Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. France Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. United Kingdom Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Russia Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Italy Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Asia-Pacific Transdermal Patch Drug Delivery System Sales Market Share by Type (2016-2026)
Figure 66. Asia-Pacific Transdermal Patch Drug Delivery System Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Transdermal Patch Drug Delivery System Revenue Market Share by Region (2016-2026)
Figure 68. China Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Japan Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South Korea Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. India Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Southeast Asia Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Australia Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South America Transdermal Patch Drug Delivery System Sales Market Share by Type (2016-2026)
Figure 75. South America Transdermal Patch Drug Delivery System Sales Market Share by Application (2016-2026)
Figure 76. South America Transdermal Patch Drug Delivery System Revenue Market Share by Country (2016-2026)
Figure 77. Brazil Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East and Africa Transdermal Patch Drug Delivery System Sales Market Share by Type (2016-2026)
Figure 80. Middle East and Africa Transdermal Patch Drug Delivery System Sales Market Share by Application (2016-2026)
Figure 81. Middle East and Africa Transdermal Patch Drug Delivery System Revenue Market Share by Country (2016-2026)
Figure 82. Turkey Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Saudi Arabia Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. UAE Transdermal Patch Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source